Skip to main content
Year archive

ZELIRA THERAPEUTICS LIMITED — 2023 filings

All 51 regulatory filings released by ZELIRA THERAPEUTICS LIMITED (ZLD) in 2023, sourced directly from the official regulator.

51 Filings
2023 Period
2023 filings (51)
Filing Released Lang
Notification regarding unquoted securities - ZLD 5 pages 26.3KB
Share Issue/Capital Change
2023-11-23 English
Change of Director's Interest Notice x 5 12 pages 543.1KB
Director's Dealing
2023-11-23 English
Proposed issue of securities - ZLD 12 pages 52.5KB
Capital/Financing Update
2023-11-22 English
2023 Annual General Meeting Presentation 17 pages 18.6MB
AGM Information
2023-11-14 English
Results of Meeting 3 pages 517.6KB
Declaration of Voting Results & Voting Rights Announcements
2023-11-14 English
Notification of cessation of securities - ZLD 4 pages 23.8KB
Share Issue/Capital Change
2023-11-12 English
Notification of cessation of securities - ZLD 4 pages 23.8KB
Share Issue/Capital Change
2023-11-02 English
September 2023 Quarterly Activities Report 5 pages 1.7MB
Interim / Quarterly Report
2023-10-30 English
Appendix 4C Cash Flow Report 5 pages 275.3KB
Interim / Quarterly Report
2023-10-30 English
Notice of Annual General Meeting/Proxy Form 38 pages 444.8KB
AGM Information
2023-10-15 English
Letter to Shareholders 2 pages 175.6KB
AGM Information
2023-10-15 English
Annual Report to shareholders 72 pages 1.9MB
Regulatory Filings
2023-09-28 English
Appendix 4G and Corporate Governance Statement 20 pages 589.9KB
Regulatory Filings
2023-09-28 English
AGM Date and Closing Date for Director Nominations 2 pages 266.2KB
AGM Information
2023-09-14 English
Change of registry address notification 2 pages 283.1KB
Regulatory Filings
2023-09-14 English
Notification of cessation of securities - ZLD 6 pages 28.4KB
Regulatory Filings
2023-09-10 English
Change of Director's Interest Notice 3 pages 236.1KB
Director's Dealing
2023-09-10 English
Preliminary Final Report 15 pages 575.8KB
Annual Report
2023-08-30 English
Zelira closes $3.25M funding as part of HOPE SPV fundraise 3 pages 1.9MB
Capital/Financing Update
2023-08-16 English
Notification of cessation of securities - ZLD 4 pages 24.0KB
Share Issue/Capital Change
2023-08-13 English
June 2023 Quarterly Activities Report 5 pages 1.8MB
Interim / Quarterly Report
2023-07-30 English
Appendix 4C Cash Flow Report 5 pages 245.2KB
Interim / Quarterly Report
2023-07-30 English
Amendment to ASX announcement - Zelira's diabetic nerve pai 8 pages 1.7MB
Regulatory Filings
2023-06-07 English
Final Director's Interest Notice 2 pages 203.4KB
Director's Dealing
2023-05-31 English
Initial Director's Interest Notice 2 pages 160.3KB
Director's Dealing
2023-05-31 English
Zeliras diabetic nerve pain drug outperforms Lyrica 6 pages 364.2KB
Regulatory Filings
2023-05-30 English
Investor Webinar - Top line trial results 2 pages 1.5MB
Regulatory Filings
2023-05-30 English
Top Line Results Investor Presentation 9 pages 1.8MB
Investor Presentation
2023-05-30 English
Zelira Non-Executive Director Appointed 5 pages 332.3KB
Board/Management Information
2023-05-30 English
Proposed issue of securities - ZLD 6 pages 30.3KB
Capital/Financing Update
2023-05-30 English
Trading Halt 3 pages 300.5KB
Regulatory Filings
2023-05-28 English
ZLD secures additional US$3.25M investment in HOPE SPV 4 pages 591.1KB
Capital/Financing Update
2023-05-21 English
March 2023 Quarterly Activities Report 6 pages 1.7MB
Interim / Quarterly Report
2023-04-26 English
Appendix 4C Cash Flow Report 5 pages 163.7KB
Interim / Quarterly Report
2023-04-26 English
Application for quotation of securities - ZLD 6 pages 27.6KB
Share Issue/Capital Change
2023-03-20 English
Section 708A Cleansing Notice 1 page 245.3KB
Share Issue/Capital Change
2023-03-20 English
Zelira raises A$1.77 million from US-based investors 2 pages 1.1MB
Capital/Financing Update
2023-03-14 English
Proposed issue of securities - ZLD 5 pages 27.8KB
Capital/Financing Update
2023-03-14 English
Trading Halt 3 pages 626.7KB
Capital/Financing Update
2023-03-12 English
Appendix 4D & FY23 Interim Financial Report 32 pages 3.2MB
Interim / Quarterly Report
2023-02-27 English
Zelira HOPE 1 SPV Investor Presentation 15 pages 14.5MB
Investor Presentation
2023-02-21 English
Zelira HOPE 1 SPV Investor Briefing Webinar 2 pages 446.1KB
Regulatory Filings
2023-02-20 English
Initial Director's Interest Notice 2 pages 154.2KB
Director's Dealing
2023-02-20 English
Zelira Executive Director Appointed 3 pages 509.2KB
Board/Management Information
2023-02-19 English
Trading Halt 3 pages 289.3KB
Regulatory Filings
2023-02-16 English
ZLD secures US$8.6 million funding for HOPE 1 US FDA trials 7 pages 1.0MB
Capital/Financing Update
2023-02-14 English
Trading Halt 3 pages 289.7KB
Regulatory Filings
2023-02-12 English
December 2022 Quarterly Activities Report 7 pages 1.7MB
Interim / Quarterly Report
2023-01-30 English
Appendix 4C Cash Flow Report 5 pages 174.7KB
Interim / Quarterly Report
2023-01-30 English
Zelira receives $1.14 million cash R&D Tax Incentive 3 pages 1.1MB
Capital/Financing Update
2023-01-29 English
Receipt of Creso Shares and Settlement of Health House loan 3 pages 1.2MB
Capital/Financing Update
2023-01-09 English